Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
VZ$46.71+0.54(+1.17%)Verizon Makes the Holidays Simple with Our Best Deals and Rewards Just for Being a Customer8:01:25 AM ETAAPL$354.10+4.59(+1.31%)The new moto buds ultra 27 take audio up a notch with Sound by Bose technology and bring AI live translation to consumers8:00:00 AM ETTM$217.02+17.56(+8.80%)2027 Toyota Tundra: A Bold New Chapter in Full-Size Pickup Excellence with Advanced Towing Tech and the New Trailhunter Package8:00:00 AM ETIBM$256.25+1.93(+0.76%)Oak Ridge National Laboratory, IBM, and AMD Launch New Co-Design Platform for Quantum Error Correction8:00:00 AM ETAAPL$354.10+4.59(+1.31%)Apple: Demand Is Not The Problem7:54:50 AM ETMCD$281.93+1.71(+0.61%)McDonald's Is Rallying, but Can You Sleep at Night Owning It?7:48:44 AM ETPLTR$167.06-4.64(-2.70%)Palantir's CEO Just Said What Wall Street Doesn't Want to Hear About AI7:47:36 AM ETMSFT$557.00+1.20(+0.22%)The Same $10,000 in Microsoft and Meta Could Produce Very Different Results by 20307:47:14 AM ETQCOM$154.90-18.29(-10.56%)Wall Street Breakfast Podcast: The VIX Plunges In Post-Election Rally7:47:00 AM ETKO$97.22+1.34(+1.40%)If You'd Invested $1,000 Alongside Warren Buffett in Coca-Cola, Here's How Much You'd Have Today7:47:00 AM ETQCOM$154.90-18.29(-10.56%)Qualcomm Q4: This Dip Is Not The One To Buy Yet7:45:04 AM ETAXP$337.50+4.88(+1.47%)American Express vs. PayPal: Which Financial Stock Is a Better Buy for 2027?7:45:01 AM ETSPCX$132.36-3.56(-2.62%)Stack Capital Group Inc. Reports Q3-2026 Financial Results7:45:00 AM ETCOP$139.45+2.51(+1.83%)BUZZ-ConocoPhillips rises on Q3 profit beat7:40:48 AM ETTGT$165.25+2.20(+1.35%)Target Looks More Attractive Than You'd Think7:31:07 AM ETCOP$139.45+2.51(+1.83%)UPDATE 2-ConocoPhillips beats estimates on higher oil prices, raises dividend7:30:23 AM ETCOP$139.45+2.51(+1.83%)ConocoPhillips Q3 profit beats on higher prices, hikes dividend7:26:13 AM ETMETA$635.50+5.50(+0.87%)UPDATE 2-Meta sells first bonds in euros, raises €9 billion7:25:25 AM ETDTE$137.45-0.06(-0.04%)UPDATE 1-DTE Energy to sell its non-utility business for about $3 billion7:23:30 AM ETAAPL$354.10+4.59(+1.31%)Jim Cramer's Surprise Midterm Winner: Apple, Because Fewer Data Centers Could Mean Cheaper Memory7:19:09 AM ETTSLA$376.25-8.94(-2.32%)Ferrari vs. Tesla: Can the Luce Outsell the Roadster?7:18:00 AM ETMU$757.79-37.67(-4.74%)Could Buying Micron Stock Today Help Set You Up for Life?7:17:00 AM ETMSFT$557.00+1.20(+0.22%)Microsoft Is Executing an Irreproducible Balance-Sheet-Backed Infrastructure Pre-Sale at Scale7:15:58 AM ETAAPL$354.10+4.59(+1.31%)Apple Vs. Tesla: Low CapEx Only Matters if Non-Cyclical Cash Flows Come With It7:15:57 AM ET

APYX · NASDAQ

Apyx Medical Corporation

$2.67 +0.10 (+3.89%)

Company overview

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers the Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market, enabling plastic surgeons, facial plastic surgeons, and cosmetic physicians to provide controlled heat to tissue to achieve desired results, as well as J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable handpieces and OEM generators and accessories.

Sector
Healthcare
Industry
Medical - Specialties
Exchange
NASDAQ
Market cap
$112M
Employees
205
Headquarters
Clearwater, FL
Website
apyxmedical.com
CEO
Charles D. Goodwin
Listed
January 2, 2019
P/E
-11.99
Dividend yield
0.00%

Company financials

Revenue
$55.9M
Gross profit
$18M
Operating income
-$4.3M
EBITDA
-$3M
Net income
-$9.2M
EPS
-$0.22
Total assets
$63M
Total debt
$39.5M
Gross margin
32.27%
Net margin
-16.40%
Earnings yield
-8.34%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

2.142.903.674.435.19
APYX 1D NASDAQ O2.65H2.67L2.55C2.57-0.03 (-1.15%)Vol133.93K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
APYXApyx Medical Corporation Stock news Apyx Medical Q3 revenue beats estimates on AYON system demand Reuters
APYXApyx Medical Corporation Stock news BRIEF-Apyx Medical Corporation Q3 EPS USD -0.04 Reuters
APYXApyx Medical Corporation Press release Apyx Medical Corporation Reports Third Quarter 2026 Financial Results GlobeNewswire
APYXApyx Medical Corporation Legal SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Apyx Medical Corporation (NASDAQ: APYX) PRNewsWire
APYXApyx Medical Corporation Press release Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026 GlobeNewswire
APYXApyx Medical Corporation Press release Apyx Medical Corporation to Participate in Upcoming Investor Conferences GlobeNewswire
APYXApyx Medical Corporation Press release Apyx Medical Announces New Clinical Study Demonstrating Renuvion®'s Impact on Skin Quality GlobeNewswire
APYXApyx Medical Corporation Stock news Apyx Medical Corporation (NASDAQ:APYX) Receives $6.60 Consensus Target Price from Brokerages Defense World
APYXApyx Medical Corporation Stock news Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript Seeking Alpha
APYXApyx Medical Corporation Stock news Apyx Medical Q2 Earnings Call Highlights MarketBeat
APYXApyx Medical Corporation Press release Apyx Medical Corporation Reports Second Quarter 2026 Financial Results GlobeNewswire
APYXApyx Medical Corporation Press release Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 GlobeNewswire
APYXApyx Medical Corporation Stock news This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Benzinga
APYXApyx Medical Corporation Press release Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway PRNewsWire
APYXApyx Medical Corporation Press release New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion® GlobeNewswire
APYXApyx Medical Corporation Press release Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction GlobeNewswire
APYXApyx Medical Corporation Press release Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™ GlobeNewswire
APYXApyx Medical Corporation Stock news Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript Seeking Alpha
APYXApyx Medical Corporation Stock news Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates Zacks Investment Research
APYXApyx Medical Corporation Press release Apyx Medical Corporation Reports First Quarter 2026 Financial Results GlobeNewswire
See more
FAQ

Questions about Apyx Medical Corporation

What does Apyx Medical Corporation do?
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers the Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate, and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market, enabling plastic surgeons, facial plastic surgeons, and cosmetic physicians to provide controlled heat to tissue to achieve desired results, as well as J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable handpieces and OEM generators and accessories.
What is APYX's market cap?
Apyx Medical Corporation (APYX) is a listed stock with a live quote. The latest market cap on this page is $112M.
Where is Apyx Medical Corporation headquartered?
Apyx Medical Corporation is headquartered in Clearwater, FL.
How do I get APYX news from the API?
Call GET /v1/news?tickers=APYX. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does APYX news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for APYX, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the APYX price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs